PHM Canada signed onto a letter (seen below) of their failure to sign onto a temporary waiver of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) for technologies related to preventing the Covid-19 virus. The letter was addressed to Mary Ng, Minister of Small Business, Export Promotion and International Trade, and cc’ed to Pablo Rodriguez, Minister of Heritage, and David Lametti, Minister of Justice. This initiative was spearheaded by Bruce Porter, the ED of the Social Rights Advocacy Centre in Canada, in conjunction with human rights groups and scholars across Canada.
To see the full text of the letter, please click here. For the appendix outlining the legal basis for Canada’s human rights obligations to do so, please visit here.
Dear Minister Ng:
We are writing regarding Canada’s response to the formal proposal submitted by India and South Africa to the World Trade Organization (WTO) for a temporary waiver of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) in relation to products and technologies for the prevention, treatment or containment of COVID-19 (“the TRIPS waiver”) (revised on 21 May 2021 (IP/C/W/669/Rev.1).
We were hoping that Canada by now would have announced its support for this proposal following recent discussions with other WTO members, and in anticipation of a decision on this matter at the upcoming Ministerial meeting scheduled for November 30th.
As you know, more than 100 WTO Members have expressed support for the TRIPS waiver, and more than 60 WTO Members have agreed to co-sponsor the proposal. The United States has supported the waiver as it applies to SARS-CoV-2 vaccines. However, Canada has to date declined to support the waiver proposal and, along with a few other WTO members, has prevented its adoption by consensus.
Minister, the consequences of a failure to adopt the TRIPS waiver could be millions of lives, both in those countries that have little or no access to necessary products and technologies and in countries such as Canada where residents continue to be vulnerable to new variants of COVID-19. It is widely affirmed by experts, including Canada’s own Chief Public Health Officer, that an effective strategy to limit the spread of COVID-19, to help prevent the emergence of more transmissible or deadly variants, and to protect life and health in all countries is to ensure that vaccines are made widely available in all countries, not just in high-income countries. Prime Minister Trudeau has repeatedly stated this undisputed fact.
The UN Secretary General observed on September 22, 2021 at the COVID-19 Global Summit that high-income countries have administered 61 times more doses per inhabitant than low-income countries and just 3 percent of Africans have been vaccinated. He emphasized that low- and middle-income countries must be able to develop and access health technologies. On October 14, 2021 a number of UN human rights special procedures mandate holders issued a letter to Canada and other States that are refusing to support the TRIPS waiver, emphasizing in their Communique that: “States have a collective responsibility to use all available means to facilitate faster access to vaccines, including by introducing a temporary waiver of relevant intellectual property rights under [TRIPS], to ensure that protection of patents concerning the vaccines does not become a barriers to the effective enjoyment of the right to health.”
UN human rights treaty monitoring bodies have also made it clear that a failure to support the TRIPS waiver would violate Canada’s obligations under ratified international human rights treaties and other international human rights law. These include obligations of international co-operation to ensure rights to health and life, as summarized in the Appendix. Obstructing the adoption of the TRIPS waiver would, in our view, breach Canada’s legal duty to perform these international human rights obligations in good faith, as required under the Vienna Convention on the Law of Treaties. We believe that obstructing the adoption of the TRIPS waiver would also violate the Canadian Charter of Rights and Freedoms, which must be interpreted in accordance with binding international human rights norms. It would violate the rights of vulnerable residents of Canada to life and security of the person under section 7 of the Canadian Charter and the rights of women, the elderly, persons with disabilities, Indigenous Peoples, Black people, other racialized persons, persons experiencing poverty and other groups protected under section 15 that are disproportionally affected.
These breaches of peremptory norms of international law and of the Charter could be the basis of legal challenges in Canadian courts in co-ordination with similar litigation initiatives in several other countries that have failed to support the proposed waiver.
However, we remain confident that Canada and other WTO members will decide to support the TRIPS waiver at the upcoming Ministerial meeting and thereby avoid the need for any judicial review in domestic courts.
Thank you for your consideration of this urgent matter.